Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 68 studies with search of: | "Decitabine" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
|
||||
2 | Recruiting |
Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia
|
||||
3 | Recruiting |
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
|
||||
4 | Active, not recruiting |
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
|
||||
5 | Recruiting |
Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma
|
||||
6 | Recruiting |
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
|
||||
7 | Completed |
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure
|
||||
8 | Recruiting |
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
|
||||
9 | Completed |
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
|
||||
10 | Not yet recruiting |
KRAS Wild-Type Metastatic Colorectal Cancer Trial
|
||||
11 | Recruiting |
LBH589 Plus Decitabine for Myelodysplastic Syndromes or Acute Myeloid Leukemia
|
||||
12 | Recruiting |
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS
|
||||
13 | Completed |
Decitabine Versus Supportive Care in Adults With Advanced-Stage MDS
|
||||
14 | Completed |
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
|
||||
15 | Completed |
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
|
||||
16 | Completed |
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
|
||||
17 | Completed |
Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia
|
||||
18 | Active, not recruiting |
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
|
||||
19 | Active, not recruiting |
A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
|
||||
20 | Recruiting |
Trial of Decitabine in Patients With Acute Myeloid Leukemia
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |